🇺🇸 Seretide in United States

10,887 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 1,949 reports (17.9%)
  2. Asthma — 1,612 reports (14.81%)
  3. Pneumonia — 1,204 reports (11.06%)
  4. Drug Ineffective — 1,082 reports (9.94%)
  5. Cough — 901 reports (8.28%)
  6. Malaise — 898 reports (8.25%)
  7. Headache — 857 reports (7.87%)
  8. Fatigue — 820 reports (7.53%)
  9. Death — 803 reports (7.38%)
  10. Nausea — 761 reports (6.99%)

Source database →

Seretide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Seretide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Seretide in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.